Latest Conference Articles

Companies Reveal Their Next Moves in Manufacturing

Companies Reveal Their Next Moves in Manufacturing

May 29th 2025

INTERPHEX

In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.

CPHI Americas 2025: The Evolving Role of the CDMO

CPHI Americas 2025: The Evolving Role of the CDMO

May 28th 2025

Christy Eatmon of Thermo Fisher Scientific reviewed her company’s experience at CPHI Americas 2025 and discussed recent industry trends that are driving strategic partnerships.

Geopolitical Shifts Change Nature of Pharma Partnerships

Geopolitical Shifts Change Nature of Pharma Partnerships

May 28th 2025

INTERPHEX

The concerns of industry experts expressed at INTERPHEX in April 2025 are still pertinent in an uncertain global political climate.

AAPS National Biotechnology Conference 2025: High-Concentration Biologics

AAPS National Biotechnology Conference 2025: High-Concentration Biologics

May 7th 2025

BioPharm International® spoke with Lun Xin, associate director at WuXi Biologics, about high-concentration biologics and some of the biggest challenges associated with their formulation.

AAPS National Biotechnology Conference 2025: AAV Vector Production

AAPS National Biotechnology Conference 2025: AAV Vector Production

May 7th 2025

BioPharm International® sat down with Noah Kopcho, field application scientist at Gyros Protein Technologies, to talk about the challenges in the production of AAV vectors.

GSK Previews Oral and Poster Abstracts for ATS International Congress

GSK Previews Oral and Poster Abstracts for ATS International Congress

May 5th 2025

The company is presenting data related to its medications designed to advance the prevention and treatment of asthma and COPD.

Capsida Previews Its Oral and Poster Presentations for ASGCT 2025

Capsida Previews Its Oral and Poster Presentations for ASGCT 2025

April 29th 2025

Conference

The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.

Tariff Pause Reinforces Uncertainty Among Biopharma Professionals

Tariff Pause Reinforces Uncertainty Among Biopharma Professionals

April 10th 2025

INTERPHEX

Even with, or perhaps because of, the rapidity with which changes in United States policy are developing, many in the bio/pharmaceutical industry are taking a longer view.

INTERPHEX 2025: Preventing Spills in the Manufacturing Process

INTERPHEX 2025: Preventing Spills in the Manufacturing Process

April 8th 2025

INTERPHEX

Joe Bobacher of OPW Engineered Systems spoke with Pharmaceutical Technology® Group at INTERPHEX 2025 about fluid transfer in controlled environments and the importance of guarding against product loss.

INTERPHEX 2025: ‘Breaking Up the Octopus’ of Single-Use Systems

INTERPHEX 2025: ‘Breaking Up the Octopus’ of Single-Use Systems

April 7th 2025

INTERPHEX

As single use becomes more prevalent, end users are looking for more customization, and regulators are refining their rules, says Todd Andrews of CPC in an interview with Pharmaceutical Technology® Group.